2,060
Views
0
CrossRef citations to date
0
Altmetric
Case Report

A new method to treat onychopapilloma with pulsed dye laser irradiation: a 13-case series report

, , , , , , ORCID Icon, , , & ORCID Icon show all
Article: 2213363 | Received 16 Feb 2023, Accepted 04 Apr 2023, Published online: 01 Jun 2023

Figures & data

Table 1. Clinical characteristics of 13 patients with onychopapilloma.

Figure 1. An intense purpuric response to PDL irradiation as the clinical endpoint.

Figure 1. An intense purpuric response to PDL irradiation as the clinical endpoint.

Figure 2. Comparison between pre- and post- PDL irradiation in three typical cases. (a) Case 1, female, 56 years, right thumb, longitudinal erythronychia. (b) Case 1, five years after two sessions of PDL irradiation. (c) Case 2, female, 35 years, left index finger, longitudinal erythronychia with distal fissuring and splinter hemorrhages. (d) Case 2, three years after one session of PDL irradiation. (e) Case 3, female, 24 years, left thumb, longitudinal leukonychia with onycholysis and V-shaped distal notch. (f) Case 3, one year after five sessions of PDL irradiation.

Figure 2. Comparison between pre- and post- PDL irradiation in three typical cases. (a) Case 1, female, 56 years, right thumb, longitudinal erythronychia. (b) Case 1, five years after two sessions of PDL irradiation. (c) Case 2, female, 35 years, left index finger, longitudinal erythronychia with distal fissuring and splinter hemorrhages. (d) Case 2, three years after one session of PDL irradiation. (e) Case 3, female, 24 years, left thumb, longitudinal leukonychia with onycholysis and V-shaped distal notch. (f) Case 3, one year after five sessions of PDL irradiation.

Figure 3. Characteristics of dermoscopic examination. (a) Subungual splinter hemorrhages. (b) Telangiectasia at the area of nail folds.

Figure 3. Characteristics of dermoscopic examination. (a) Subungual splinter hemorrhages. (b) Telangiectasia at the area of nail folds.

Data availability statement

The authors are unable to provide individual patient data as consent for distribution of personal information was not obtained in the report.